TSC2 c.4105C>A ;(p.R1369=)

Variant ID: 16-2134328-C-A

NM_000548.3(TSC2):c.4105C>A;(p.R1369=)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.

Oncogene
Nickerson, M L ML; Witte, N N; Im, K M KM; Turan, S S; Owens, C C; Misner, K K; Tsang, S X SX; Cai, Z Z; Wu, S S; Dean, M M; Costello, J C JC; Theodorescu, D D
Publication Date: 2017-01-05

Variant appearance in text: rs45517328
PubMed Link: 27270441
Variant Present in the following documents:
  • onc2016172x3.xls, sheet 3
View BVdb publication page



KRAS and DAXX/ATRX gene mutations are correlated with the clinicopathological features, advanced diseases, and poor prognosis in Chinese patients with pancreatic neuroendocrine tumors.

International Journal Of Biological Sciences
Yuan, Fei F; Shi, Min M; Ji, Jun J; Shi, Hailong H; Zhou, Chenfei C; Yu, Yingyan Y; Liu, Bingya B; Zhu, Zhenggang Z; Zhang, Jun J
Publication Date: 2014

Variant appearance in text: rs45517328
PubMed Link: 25210493
Variant Present in the following documents:
  • Main text
  • ijbsv10p0957.pdf
View BVdb publication page